{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:59:50Z","timestamp":1793051990641,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170755"],"award-info":[{"award-number":["82170755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic kidney disease (DKD) has been the leading cause of chronic kidney disease in developed countries. Evidence of the benefits of resveratrol (RES) for the treatment of DKD is accumulating. However, comprehensive therapeutic targets and underlying mechanisms through which RES exerts its effects against DKD are limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Drug targets of RES were obtained from Drugbank and SwissTargetPrediction Databases. Disease targets of DKD were obtained from DisGeNET, Genecards, and Therapeutic Target Database. Therapeutic targets for RES against DKD were identified by intersecting the drug targets and disease targets. GO functional enrichment analysis, KEGG pathway analysis, and disease association analysis were performed using the DAVID database and visualized by Cytoscape software. Molecular docking validation of the binding capacity between RES and targets was performed by UCSF Chimera software and SwissDock webserver. The high glucose (HG)-induced podocyte injury model, RT-qPCR, and western blot were used to verify the reliability of the effects of RES on target proteins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After the intersection of the 86 drug targets and 566 disease targets, 25 therapeutic targets for RES against DKD were obtained. And the target proteins were classified into 6 functional categories. A total of 11 cellular components terms and 27 diseases, and the top 20 enriched biological processes, molecular functions, and KEGG pathways potentially involved in the RES action against DKD were recorded. Molecular docking studies showed that RES had a strong binding affinity toward PPARA, ESR1, SLC2A1, SHBG, AR, AKR1B1, PPARG, IGF1R, RELA, PIK3CA, MMP9, AKT1, INSR, MMP2, TTR, and\u00a0CYP2C9 domains. The HG-induced podocyte injury model was successfully constructed and validated by RT-qPCR and western blot. RES treatment was able to reverse the abnormal gene expression of PPARA, SHBG, AKR1B1, PPARG, IGF1R, MMP9, AKT1, and INSR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>RES may target PPARA, SHBG, AKR1B1, PPARG, IGF1R, MMP9, AKT1, and INSR domains to act as a therapeutic agent for DKD. These findings comprehensively reveal the potential therapeutic targets for RES against DKD and provide theoretical bases for the clinical application of RES in the treatment of DKD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04233-0","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T06:02:01Z","timestamp":1686549721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation"],"prefix":"10.1186","volume":"21","author":[{"given":"Shengnan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-6112","authenticated-orcid":false,"given":"Hongli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"4233_CR1","volume-title":"Idf diabetes atlas","author":"DJ Magliano","year":"2021","unstructured":"Magliano DJ, Boyko EJ, Committee IDF DATES, IDF Diabetes Atlas [M]. Idf diabetes atlas. Brussels: International Diabetes Federation; 2021."},{"key":"4233_CR2","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37:2864\u201383.","journal-title":"Diabetes Care"},{"key":"4233_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","volume":"25","author":"DN Koye","year":"2018","unstructured":"Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25:121\u201332.","journal-title":"Adv Chronic Kidney Dis"},{"key":"4233_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892860","volume":"13","author":"X Pan","year":"2022","unstructured":"Pan X, Lin X, Huang X, Xu J, Ye L, Zhang T, et al. The Burden of diabetes-related chronic kidney disease in China from 1990 to 2019. Front Endocrinol (Lausanne). 2022;13: 892860.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4233_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102033","volume":"45","author":"X Dai","year":"2021","unstructured":"Dai X, Liao R, Liu C, Liu S, Huang H, Liu J, et al. Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol. 2021;45: 102033.","journal-title":"Redox Biol"},{"key":"4233_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang C, Livingston MJ, Liu Z, Dong Z. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020;16:489\u2013508.","journal-title":"Nat Rev Nephrol"},{"key":"4233_CR7","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s13300-020-00843-9","volume":"11","author":"A Roborel de Climens","year":"2020","unstructured":"Roborel de Climens A, Pain E, Boss A, Shaunik A. Understanding reasons for treatment discontinuation, attitudes and education needs among people who discontinue type\u00a02 diabetes treatment: results from an online patient survey in the USA and UK. Diabetes Ther. 2020;11:1873\u201381.","journal-title":"Diabetes Ther."},{"key":"4233_CR8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/ph14080806","volume":"14","author":"J Blahova","year":"2021","unstructured":"Blahova J, Martiniakova M, Babikova M, Kovacova V, Mondockova V, Omelka R. Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus. Pharmaceuticals. 2021;14:806.","journal-title":"Pharmaceuticals"},{"key":"4233_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biochi.2020.01.007","volume":"170","author":"K Kushwaha","year":"2020","unstructured":"Kushwaha K, Sharma S, Gupta J. Metabolic memory and diabetic nephropathy: beneficial effects of natural epigenetic modifiers. Biochimie. 2020;170:140\u201351.","journal-title":"Biochimie"},{"key":"4233_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.semcancer.2020.06.014","volume":"80","author":"E Khatoon","year":"2022","unstructured":"Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, et al. Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives. Semin Cancer Biol. 2022;80:306\u201339.","journal-title":"Semin Cancer Biol"},{"key":"4233_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109767","volume":"125","author":"DD Huang","year":"2020","unstructured":"Huang DD, Shi G, Jiang Y, Yao C, Zhu C. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother. 2020;125: 109767.","journal-title":"Biomed Pharmacother"},{"key":"4233_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00018-022-04551-4","volume":"79","author":"M Behroozaghdam","year":"2022","unstructured":"Behroozaghdam M, Dehghani M, Zabolian A, Kamali D, Javanshir S, Hasani Sadi F, et al. Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cell Mol Life Sci. 2022;79:539.","journal-title":"Cell Mol Life Sci"},{"key":"4233_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.diabet.2018.05.010","volume":"45","author":"A Sattarinezhad","year":"2019","unstructured":"Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol reduces albuminuria in diabetic nephropathy: a randomized double-blind placebo-controlled clinical trial. Diabetes Metab. 2019;45:53\u20139.","journal-title":"Diabetes Metab"},{"key":"4233_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/S0007114511000316","volume":"106","author":"P Brasny\u00f3","year":"2011","unstructured":"Brasny\u00f3 P, Moln\u00e1r GA, Moh\u00e1s M, Mark\u00f3 L, Laczy B, Cseh J, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106:383\u20139.","journal-title":"Br J Nutr"},{"key":"4233_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fphar.2020.00425","volume":"11","author":"S Zhou","year":"2020","unstructured":"Zhou S, Ai Z, Li W, You P, Wu C, Li L, et al. Deciphering the pharmacological mechanisms of taohe-chengqi decoction extract against renal fibrosis through integrating network pharmacology and experimental validation in vitro and in vivo. Front Pharmacol. 2020;11:425.","journal-title":"Front Pharmacol"},{"key":"4233_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fphar.2019.01185","volume":"10","author":"W Guo","year":"2019","unstructured":"Guo W, Huang J, Wang N, Tan HY, Cheung F, Chen F, et al. Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma. Front Pharmacol. 2019;10:1185.","journal-title":"Front Pharmacol"},{"key":"4233_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1039\/D1SC05613A","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, Ma H, Liu Z, Zheng L, Yu Z, Cao S, et al. wSDTNBI: a novel network-based inference method for virtual screening. Chem Sci. 2022;13:1060\u201379.","journal-title":"Chem Sci"},{"key":"4233_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/biom9080362","volume":"9","author":"W-Y Lee","year":"2019","unstructured":"Lee W-Y, Lee C-Y, Kim Y-S, Kim C-E. The methodological trends of traditional herbal medicine employing network pharmacology. Biomolecules. 2019;9:362.","journal-title":"Biomolecules"},{"key":"4233_CR19","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liu X, Hu X, Gao L, Zeng H, Wang X, et al. METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Mol Ther. 2022;30:1721\u201340.","journal-title":"Mol Ther"},{"key":"4233_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","volume":"124","author":"K Reidy","year":"2014","unstructured":"Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124:2333\u201340.","journal-title":"J Clin Invest"},{"key":"4233_CR21","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1038\/s41467-019-12433-w","volume":"10","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Lee K, Deng Y, Ma Y, Chen Y, Li X, et al. Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nat Commun. 2019;10:4523.","journal-title":"Nat Commun"},{"key":"4233_CR22","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2017","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017;46:D1074\u201382.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR23","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357\u201364.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR24","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J, Ronzano F, Centeno E, Sanz F, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48:D845\u201355.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR25","doi-asserted-by":"publisher","first-page":"baq020","DOI":"10.1093\/database\/baq020","volume":"2010","author":"M Safran","year":"2010","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:baq020.","journal-title":"Database (Oxford)."},{"key":"4233_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/30.1.412","volume":"30","author":"X Chen","year":"2002","unstructured":"Chen X, Ji ZL, Chen YZTTD. Therapeutic target database. Nucleic Acids Res. 2002;30:412\u20135.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR27","doi-asserted-by":"publisher","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","volume":"49","author":"H Mi","year":"2021","unstructured":"Mi H, Ebert D, Muruganujan A, Mills C, Albou LP, Mushayamaha T, et al. PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API. Nucleic Acids Res. 2021;49:D394-d403.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR28","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR29","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.","journal-title":"Genome Biol"},{"key":"4233_CR30","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202\u201313.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:33.","journal-title":"J Cheminform"},{"key":"4233_CR32","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gku377","volume":"42","author":"CC Huang","year":"2014","unstructured":"Huang CC, Meng EC, Morris JH, Pettersen EF, Ferrin TE. Enhancing UCSF Chimera through web services. Nucleic Acids Res. 2014;42:W478\u201384.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR33","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"UniProt Consortium","year":"2021","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480\u20139.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28:235\u201342.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR35","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011;39:W270\u20137.","journal-title":"Nucleic Acids Res"},{"key":"4233_CR36","first-page":"1677","volume":"33","author":"RC Yang","year":"2013","unstructured":"Yang RC, Zhu XL, Zhang HQ, Li WD. Study of resveratrol suppressing TGF-beta1 induced transdifferentiation of podocytes. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013;33:1677\u201382.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"4233_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12920-023-01519-6","volume":"16","author":"S Chen","year":"2023","unstructured":"Chen S, Li B, Chen L, Jiang H. Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease. BMC Med Genomics. 2023;16:90.","journal-title":"BMC Med Genomics"},{"key":"4233_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.fct.2013.06.037","volume":"59","author":"MK Sangeetha","year":"2013","unstructured":"Sangeetha MK, Vallabi DE, Sali VK, Thanka J, Vasanthi HR. Sub-acute toxicity profile of a modified resveratrol supplement. Food Chem Toxicol. 2013;59:492\u2013500.","journal-title":"Food Chem Toxicol"},{"key":"4233_CR39","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.3390\/ijms22137060","volume":"22","author":"X Huang","year":"2021","unstructured":"Huang X, Pearce R, Omenn GS, Zhang Y. Identification of 13 guanidinobenzoyl- or aminidinobenzoyl-containing drugs to potentially inhibit TMPRSS2 for COVID-19 treatment. Int J Mol Sci. 2021;22:7060.","journal-title":"Int J Mol Sci"},{"key":"4233_CR40","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.3390\/ijms21207648","volume":"21","author":"NA Murugan","year":"2020","unstructured":"Murugan NA, Muvva C, Jeyarajpandian C, Jeyakanthan J, Subramanian V. Performance of force-field- and machine learning-based scoring functions in ranking MAO-B protein-inhibitor complexes in relevance to developing Parkinson\u2019s therapeutics. Int J Mol Sci. 2020;21:7648.","journal-title":"Int J Mol Sci"},{"key":"4233_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/pharmaceutics13060781","volume":"13","author":"M Kadela-Tomanek","year":"2021","unstructured":"Kadela-Tomanek M, Jastrz\u0119bska M, Marciniec K, Chrobak E, B\u0119benek E, Boryczka S. Lipophilicity, pharmacokinetic properties, and molecular docking study on SARS-CoV-2 target for betulin triazole derivatives with attached 1,4-quinone. Pharmaceutics. 2021;13:781.","journal-title":"Pharmaceutics"},{"key":"4233_CR42","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1113\/JP278082","volume":"597","author":"GM Brawerman","year":"2019","unstructured":"Brawerman GM, Kereliuk SM, Brar N, Cole LK, Seshadri N, Pereira TJ, et al. Maternal resveratrol administration protects against gestational diabetes-induced glucose intolerance and islet dysfunction in the rat offspring. J Physiol. 2019;597:4175\u201392.","journal-title":"J Physiol"},{"key":"4233_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cbic.201300754","volume":"15","author":"E Calleri","year":"2014","unstructured":"Calleri E, Pochetti G, Dossou KSS, Laghezza A, Montanari R, Capelli D, et al. Resveratrol and its metabolites bind to PPARs. ChemBioChem. 2014;15:1154\u201360.","journal-title":"ChemBioChem"},{"key":"4233_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-016-0922-9","volume":"14","author":"HS Park","year":"2016","unstructured":"Park HS, Lim JH, Kim MY, Kim Y, Hong YA, Choi SR, et al. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy. J Transl Med. 2016;14:176.","journal-title":"J Transl Med"},{"key":"4233_CR45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3892\/ijmm_00000416","volume":"25","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Luo Z, Ma L, Xu Q, Yang Q, Si L. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med. 2010;25:729\u201334.","journal-title":"Int J Mol Med"},{"key":"4233_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/biof.1531","volume":"45","author":"F Hajizadeh-Sharafabad","year":"2019","unstructured":"Hajizadeh-Sharafabad F, Sahebkar A, Zabetian-Targhi F, Maleki V. The impact of resveratrol on toxicity and related complications of advanced glycation end products: a systematic review. BioFactors. 2019;45:651\u201365.","journal-title":"BioFactors"},{"key":"4233_CR47","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1002\/jcp.27306","volume":"234","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chi Y, Kang Y, Lu H, Niu H, Liu W, et al. Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1\/PGC-1\u03b1 mediated attenuation of mitochondrial oxidative stress. J Cell Physiol. 2019;234:5033\u201343.","journal-title":"J Cell Physiol"},{"key":"4233_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.rbmo.2020.10.003","volume":"42","author":"Y Li","year":"2021","unstructured":"Li Y, Fang L, Yan Y, Wang Z, Wu Z, Jia Q, et al. Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis. Reprod Biomed Online. 2021;42:227\u201336.","journal-title":"Reprod Biomed Online"},{"key":"4233_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","volume":"499","author":"JL Zhu","year":"2019","unstructured":"Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142\u20138.","journal-title":"Clin Chim Acta"},{"key":"4233_CR50","doi-asserted-by":"publisher","first-page":"12284","DOI":"10.1038\/s41598-017-12509-x","volume":"7","author":"C Saez-Lopez","year":"2017","unstructured":"Saez-Lopez C, Brianso-Llort L, Torres-Torronteras J, Sim\u00f3 R, Hammond GL, Selva DM. Resveratrol increases hepatic SHBG expression through human constitutive androstane receptor: a new contribution to the French paradox. Sci Rep. 2017;7:12284.","journal-title":"Sci Rep"},{"key":"4233_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10408444.2020.1762538","volume":"50","author":"RJ Qasem","year":"2020","unstructured":"Qasem RJ. The estrogenic activity of resveratrol: a comprehensive review of in vitro and in vivo evidence and the potential for endocrine disruption. Crit Rev Toxicol. 2020;50:439\u201362.","journal-title":"Crit Rev Toxicol"},{"key":"4233_CR52","doi-asserted-by":"publisher","first-page":"8890","DOI":"10.1111\/jcmm.15581","volume":"24","author":"R Khayami","year":"2020","unstructured":"Khayami R, Hashemi SR, Kerachian MA. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential. J Cell Mol Med. 2020;24:8890\u2013902.","journal-title":"J Cell Mol Med"},{"key":"4233_CR53","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/biology11091324","volume":"11","author":"F Balestri","year":"2022","unstructured":"Balestri F, Poli G, Piazza L, Cappiello M, Moschini R, Signore G, et al. Dissecting the activity of catechins as incomplete aldose reductase differential inhibitors through kinetic and computational approaches. Biology. 2022;11:1324.","journal-title":"Biology"},{"key":"4233_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/antiox9040273","volume":"9","author":"T-T Wu","year":"2020","unstructured":"Wu T-T, Chen Y-Y, Chang H-Y, Kung Y-H, Tseng C-J, Cheng P-W. AKR1B1-induced epithelial\u2013mesenchymal transition mediated by RAGE-oxidative stress in diabetic cataract lens. Antioxidants. 2020;9:27.","journal-title":"Antioxidants"},{"key":"4233_CR55","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1152\/ajpendo.00071.2019","volume":"317","author":"R Dong","year":"2019","unstructured":"Dong R, Yu J, Yu F, Yang S, Qian Q, Zha Y. IGF-1\/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model. Am J Physiol Endocrinol Metab. 2019;317:E686\u201398.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4233_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/aps.2015.128","volume":"37","author":"YL Kong","year":"2016","unstructured":"Kong YL, Shen Y, Ni J, Shao DC, Miao NJ, Xu JL, et al. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1\/IGF-1R pathway. Acta Pharmacol Sin. 2016;37:217\u201327.","journal-title":"Acta Pharmacol Sin"},{"key":"4233_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1471-2407-10-238","volume":"10","author":"J Vanamala","year":"2010","unstructured":"Vanamala J, Reddivari L, Radhakrishnan S, Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R\/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010;10:238.","journal-title":"BMC Cancer"},{"key":"4233_CR58","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1210\/endo.139.3.5832","volume":"139","author":"C Ohlsson","year":"1998","unstructured":"Ohlsson C, Kley N, Werner H, Leroith D. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology. 1998;139:1101\u20137.","journal-title":"Endocrinology"},{"key":"4233_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.767654","volume":"12","author":"G Li","year":"2021","unstructured":"Li G, Zhang J, Liu D, Wei Q, Wang H, Lv Y, et al. Identification of Hub genes and potential ceRNA networks of diabetic nephropathy by weighted gene co-expression network analysis. Front Genet. 2021;12: 767654.","journal-title":"Front Genet"},{"key":"4233_CR60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ki.2014.67","volume":"86","author":"SY Li","year":"2014","unstructured":"Li SY, Huang PH, Yang AH, Tarng DC, Yang WC, Lin CC, et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int. 2014;86:358\u201369.","journal-title":"Kidney Int"},{"key":"4233_CR61","doi-asserted-by":"publisher","first-page":"8709","DOI":"10.1007\/s11033-012-1728-3","volume":"39","author":"YS Kim","year":"2012","unstructured":"Kim YS, Sull JW, Sung HJ. Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells. Mol Biol Rep. 2012;39:8709\u201316.","journal-title":"Mol Biol Rep"},{"key":"4233_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1039\/C3FO60236B","volume":"5","author":"J Walker","year":"2014","unstructured":"Walker J, Schueller K, Schaefer LM, Pignitter M, Esefelder L, Somoza V. Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations. Food Funct. 2014;5:74\u201384.","journal-title":"Food Funct"},{"key":"4233_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/cns.12194","volume":"20","author":"AW Shao","year":"2014","unstructured":"Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM, Hong Y. Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-\u03baB-dependent inflammatory\/MMP-9 pathway. CNS Neurosci Ther. 2014;20:182\u20135.","journal-title":"CNS Neurosci Ther"},{"key":"4233_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/or.2014.3192","volume":"32","author":"EJ Gweon","year":"2014","unstructured":"Gweon EJ, Kim SJ. Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways. Oncol Rep. 2014;32:71\u20138.","journal-title":"Oncol Rep"},{"key":"4233_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.08.035","volume":"838","author":"N Razali","year":"2018","unstructured":"Razali N, Agarwal R, Agarwal P, Froemming GRA, Tripathy M, Ismail NM. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-\u03b22 signaling pathways. Eur J Pharmacol. 2018;838:1\u201310.","journal-title":"Eur J Pharmacol"},{"key":"4233_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ndt\/gfs387","volume":"28","author":"Y Takamiya","year":"2013","unstructured":"Takamiya Y, Fukami K, Yamagishi S, Kaida Y, Nakayama Y, Obara N, et al. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice. Nephrol Dial Transplant. 2013;28:55\u201362.","journal-title":"Nephrol Dial Transplant"},{"key":"4233_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.619252","volume":"8","author":"M McKenna","year":"2020","unstructured":"McKenna M, Balasuriya N, Zhong S, Li SS, O\u2019Donoghue P. Phospho-form specific substrates of protein kinase B (AKT1). Front Bioeng Biotechnol. 2020;8: 619252.","journal-title":"Front Bioeng Biotechnol"},{"key":"4233_CR68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2337\/diab.39.2.129","volume":"39","author":"S Seino","year":"1990","unstructured":"Seino S, Seino M, Bell GI. Human insulin-receptor gene. Diabetes. 1990;39:129\u201333.","journal-title":"Diabetes"},{"key":"4233_CR69","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1039\/D0FO02387F","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun X, Cao Z, Ma Y, Shao Y, Zhang J, Yuan G, et al. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K\/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes. Food Funct. 2021;12:1207\u201318.","journal-title":"Food Funct"},{"key":"4233_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gendis.2018.06.001","volume":"5","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang K, Wan W, Cheng Y, Pu X, Ye X. Resveratrol provides neuroprotection by regulating the JAK2\/STAT3\/PI3K\/AKT\/mTOR pathway after stroke in rats. Genes Dis. 2018;5:245\u201355.","journal-title":"Genes Dis"},{"key":"4233_CR71","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/FJC.0000000000000504","volume":"70","author":"Z Wu","year":"2017","unstructured":"Wu Z, Huang A, Yan J, Liu B, Liu Q, Zhang J, et al. Resveratrol ameliorates cardiac dysfunction by inhibiting apoptosis via the PI3K\/Akt\/FoxO3a pathway in a rat model of diabetic cardiomyopathy. J Cardiovasc Pharmacol. 2017;70:184\u201393.","journal-title":"J Cardiovasc Pharmacol"},{"key":"4233_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101070","volume":"9","author":"TC Hsieh","year":"2014","unstructured":"Hsieh TC, Lin CY, Bennett DJ, Wu E, Wu JM. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2. PLoS ONE. 2014;9: e101070.","journal-title":"PLoS ONE"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04233-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T07:07:53Z","timestamp":1686553673000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04233-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4233"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04233-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}